| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa48a431ce250933eb0fdd7a1caf3f30 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 |
| filingDate |
1993-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eeff2ee8b527f193a03af77af20cdb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_addf0c272e3e2f9bb5556eaa5e954c60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1eb6f1257c6515cee7e975c5a3e49fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a46524d0cbf4a08785b9106a7f640e37 |
| publicationDate |
2001-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6287598-B1 |
| titleOfInvention |
Method for providing sustained antiepileptic therapy |
| abstract |
This invention pertains to a dosage form for the management of epilepsies wherein the dosage form comprises administering valproic acid or a valproic acid derivative at a continuous rate over an extended time. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007160667-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7713550-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005255038-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008081069-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003212142-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003211148-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005276848-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005276850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005215487-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1815850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005107310-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010172986-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7217696-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005153928-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007081341-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004204495-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009525953-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005276849-A1 |
| priorityDate |
1993-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |